First steps towards molecular prevention in gastric carcinogenesis.
Ebert
Matthias P A
MP
Department of Medicine II, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. Matthias.Ebert@lrz.tum.de
Röcken
Christoph
C
D000818:Animals; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D005060:Europe; D016481:Helicobacter Infections / Q000150:complications*; D016480:Helicobacter pylori; D006801:Humans; D009656:North America; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000378:metabolism / Q000382:microbiology / Q000517:prevention & control* / Q000628:therapy
D052246:Cyclooxygenase 2 Inhibitors